✦ LIBER ✦

Comparative efficiency of intraperitoneal interleukine-2 and interferon-α in rats with experimental endometriosis

✍ Scribed by S. A. Sel’kov; R. V. Pavlov

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 636 KB
Volume: 143
Category: Article
ISSN: 0007-4888
DOI: 10.1007/s10517-007-0113-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous interleukin-2 and interfero

Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin-2 and interferon α : Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie

✍ Alain Ravaud; Rémy Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The main objective of this trial was to evaluate the combination of subcutaneous (sc) interleukin-2 (il-2) with interferon alpha-2a (ifn-alpha) in the treatment of patients with metastatic renal cell carcinoma (mrcc) compared with a previous trial that used continuous-infusion il-2 a

Comparative study of intracellular gluta

Comparative study of intracellular glutathione content in rat lymphocyte cultures treated with 2-mercaptoethanol and interleukin-2

✍ Anane Aidoo; Lascelles E. Lyn-Cook; Suzanne M. Morris; Ralph L. Kodell; Daniel A 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 613 KB

The level of intracellular glutathione (GSH) in mitogen-stimulated mouse lymphocytes is increased in the presence of 2-mercaptoethanol (2-ME), an enhancer of lymphocyte activation and proliferation. Since proliferation of lymphocytes in response to mitogens involves direct activation by a mitogen fo

Production of tumor necrosis factor α an

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

✍ James S. Economou; Mary Hoban; Jeffrey D. Lee; Richard Essner; Stephen Swisher; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 548 KB

Long-term treatment with low doses of in

Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer

✍ Laura Pavone; Simeone Andrulli; Rosaria Santi; Maria Majori; Carlo Buzio 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Long-term immunotherapy with low-dose in

Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma

✍ Carlo Buzio; Simeone Andrulli; Rosaria Santi; Laura Pavone; Rodolfo Passalacqua; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Thirteen-year, long-term efficacy of int

Thirteen-year, long-term efficacy of interferon 2α and interleukin 2-based home therapy in patients with advanced renal cell carcinoma

✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t